Real-time enrollment status for this heart failure clinical trial
Current Status
Terminated
Checked: March 2, 2026 at 7:18 AM UTC
| NCT Number | NCT06237309 |
| Recruiting Status | Terminated |
| Condition | Heart Failure |
| Phase | Clinical Trial |
| Target Enrollment | 394 participants |
| Active Locations | 4 sites in the US |
| Sponsor | Regeneron Pharmaceuticals |
| Last Updated on CT.gov | January 14, 2026 (Jan 14, 2026) |
As of March 2, 2026: Clinical trial NCT06237309 is currently terminated participants. This clinical trial study for heart failure is not currently accepting new participants at 4 locations across the United States. The study is sponsored by Regeneron Pharmaceuticals. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT06237309 is currently terminated. The study may resume recruiting in the future.
This trial is recruiting at 4 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06237309 was last updated Jan 14, 2026 (January 14, 2026). HelloStudys verifies this status automatically.